Every July 28, World Hepatitis Day reminds us that the fight against viral hepatitis is far from over. In an engaging exchange, two renowned liver surgeons—Professor Mao Yilei from the Peking Union Medical College Hospital and Professor Michael Millis from the University of Chicago Medicine—shared breakthrough insights on how a united front is combating liver cancer.
Professor Mao Yilei pointed out that improved surveillance and comprehensive prevention efforts have dramatically reduced hepatitis B infections in China. With a three-dose hepatitis B vaccination rate among newborns maintained at over 95%, recent national surveys show that the incidence among children under five is now just 0.3%. Such achievements are not only milestones in public health but also a strong defense against complications like liver damage, cirrhosis, liver failure, and ultimately liver cancer.
Both experts stressed that early screening is essential for HBV carriers and patients with cirrhosis; checks with ultrasound or CT scans every six months can make a vital difference by catching hepatocellular carcinoma in its early stages. Beyond clinical updates, the conversation highlighted vibrant collaborative efforts between the Chinese and U.S. medical communities through student exchange programs and joint conferences—proving that global teamwork is key in the fight against liver cancer.
This inspiring partnership, from Beijing to Chicago, shows that science, innovation, and cross-border collaboration can pave the way for a healthier future. Stay informed and keep an eye on more exciting developments in global health! 😊🩺
Reference(s):
From Beijing to Chicago: A united front against liver cancer
cgtn.com
